June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Studies on Transient Receptor Potential Vanilloid (TRPV) in human conjunctival epithelium.
Author Affiliations & Notes
  • Dhruva Bhattacharya
    Ophthalmology and Vision Science, University of Arizona, Tucson, Arizona, United States
  • Mingwu Wang
    Ophthalmology and Vision Science, University of Arizona, Tucson, Arizona, United States
    Cornea Associates, Tucson, Arizona, United States
  • Mohammad Shahidullah
    Ophthalmology and Vision Science, University of Arizona, Tucson, Arizona, United States
    Department of Physiology, University of Arizona College of Medicine, Tucson, Arizona, United States
  • Footnotes
    Commercial Relationships   Dhruva Bhattacharya, None; Mingwu Wang, None; Mohammad Shahidullah, None
  • Footnotes
    Support  ADHS14-082988
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 450. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Dhruva Bhattacharya, Mingwu Wang, Mohammad Shahidullah; Studies on Transient Receptor Potential Vanilloid (TRPV) in human conjunctival epithelium.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):450.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : TRPV cation channels are osmo-mechano-and-thermo-sensitive membrane proteins. These proteins are extensively involved in pathophysiology including inflammation and pain. Hyperosmotic tears and ocular surface inflammation are hallmarks of dry eye condition. Here we explore expression and osmotic modulation of TRPV1 and TRPV4 in human conjunctival epithelial cells (hCjE).

Methods : hCjE cells were cultured to confluence in supplemented Keratinocyte Serum Free Medium (GIBCO). Presence of TRPV mRNA and proteins in hCjE were determined by Reverse Transcription-Quantitative-Polymerase Chain Reaction (RT-qPCR) and western blot analysis, respectively.

Results : The RT-qPCR and western blot studies confirm the presence of TRPV1, TRPV2 and TRPV4 mRNA and proteins in hCjE cells. None of the TRPC genes were detected in the hCjE cells. Incubation of hCjE cells for 24h with 5 μM GSK 1016790A (a specific TRPV4 agonist) upregulated the TRPV4 gene by 58 folds (SEM=0.23, N=3, P=0.0001) compared to control cells. Similarly, treatment of hCjE cells with 5 μM capsaicin for 24h showed 2.6 folds (SEM=0.27, N=3, P = 0.0001) increase in TRPV1 mRNA expression compared to control cells. When cells were incubated in hyperosmotic medium (350mOsM) for 24h, TRPV1 protein level was significantly upregulated (N=3, P = 0.0008).

Conclusions : Expression of TRPV1, TRPV2 and TRPV4 and their regulation by agonists and hyperosmotic conditions in cultured hCjE signify functional presence and possibility of using this cell as an experimental platform for studying TRPV proteins under simulated dry eye condition.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×